跳至主要内容
临床试验/JPRN-UMIN000006199
JPRN-UMIN000006199已完成未知

A Clinical trial of compound drugs for patients with type2 diabetes - Comparative analysis of the characteristics of postprandial hyperglycemia improving drugs for postprandial metabolic disorder. - - A Clinical trial of compound drugs for patients with type2 diabetes - Comparative analysis of the characteristics of postprandial hyperglycemia improving drugs for postprandial metabolic disorder.

Advanced Clinical Research Organization0 个研究点目标入组 12 人开始时间: 2011年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients having been treated by sulfonylureas within 3 months. 2) Patients treated by hyperlipidemia of fibrates. 3) Patients with a BMI of 40 or more. 4) Patients falling under the [contraindication] in attached files of the experimental drugs. 5) Patients falling under the [Special caution needed] in attached files of the experimental drugs and whom have high disability, and whom principal investigator concludes to be unsuitable for the test. 6) Patients whom principal investigator concludes to be unsuitable for the test, in other reasons.

研究者

发起方
Advanced Clinical Research Organization

相似试验